A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.
AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody ...
The two partners plan to develop a series of drug cocktails based on antibodies specific to SARS-CoV-2, the virus that causes COVID-19, that they say could be used as a “protective shield ...